The application of STEP-technology® for particle and protein dispersion detection studies in biopharmaceutical research

Anfinsen, 1972, The formation and stabilization of protein structure, Biochem. J., 128, 737, 10.1042/bj1280737 Berlin, L.U.M.G., 2016. Homepage and Database of L.U.M. https://www.lum-gmbh.com/literaturdatenbank.html. Chi, 2003, Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation, Pharm. Res., 20, 1325, 10.1023/A:1025771421906 Dill, 1990, Dominant forces in protein folding, Biochemistry, 29, 7133, 10.1021/bi00483a001 Fischer, 2004, Average protein density is a molecular-weight-dependent function, Protein Sci., 13, 2825, 10.1110/ps.04688204 IUPAC, 2006. Compendium of Chemical Terminology. Blackwelll Scientific Publications, Oxford. Karow, 2015, Resolving power of dynamic light scattering for protein and polystyrene nanoparticles, Pharm. Dev. Technol., 20, 84, 10.3109/10837450.2014.910808 Lakowicz, 2006 Mahler, 2009, Protein aggregation: pathways, induction factors and analysis, J. Pharm. Sci., 98, 2909, 10.1002/jps.21566 Nicoud, 2015, A multiscale view of therapeutic protein aggregation: a colloid science perspective, Biotechnol. J., 10, 367, 10.1002/biot.201400858 Roberts, 2014, Protein aggregation and its impact on product quality, Curr. Opin. Biotechnol., 30, 211, 10.1016/j.copbio.2014.08.001 Rosenberg, 2006, Effects of protein aggregates: an immunologic perspective, AAPS J., 8, E501, 10.1208/aapsj080359 Schaefer, 2012, Atomic force microscopy and analytical ultracentrifugation for probing nanomaterial protein interactions, ACS Nano, 6, 4603, 10.1021/nn202657q Walsh, 2000, Biopharmaceutical benchmarks, Nat. Biotechnol., 18, 831, 10.1038/78720 Walsh, 2014, Biopharmaceutical benchmarks 2014, Nat. Biotechnol., 32, 992, 10.1038/nbt.3040 Walter, 2014, Multidimensional analysis of nanoparticles with highly disperse properties using multiwavelength analytical ultracentrifugation, ACS Nano, 8, 8871, 10.1021/nn503205k Walter, 2015, New possibilities of accurate particle characterisation by applying direct boundary models to analytical centrifugation, Nanoscale, 7, 6574, 10.1039/C5NR00995B Wang, 1999, Instability, stabilization, and formulation of liquid protein pharmaceuticals, Int. J. Pharm., 185, 129, 10.1016/S0378-5173(99)00152-0 Wang, 2007, Antibody structure, instability, and formulation, J Pharm. Sci., 96, 1, 10.1002/jps.20727 Wang, 2014, Quantitative evaluation of colloidal stability of antibody solutions using PEG-induced liquid-liquid phase separation, Mol. Pharm., 11, 1391, 10.1021/mp400521b Zolls, 2013, How subvisible particles become invisible-relevance of the refractive index for protein particle analysis, J. Pharm. Sci., 102, 1434, 10.1002/jps.23479